Rocket Lab (RKLB) Stock Dips Following $9.5M Insider Share Sale by Senior Vice President

Key Takeaways

• Senior Vice President Arjun Kampani offloaded 88,000 RKLB shares on June 18, generating approximately $9.5 million at $107.98 per share.
• Kampani’s holdings decreased by 24.95% following the transaction; he retains 264,705 shares valued at roughly $28.6 million.
• Shares closed at $107.24 on exceptionally high trading volume — approximately three times the typical daily average.
• First-quarter results showed 63.4% revenue growth compared to the prior year, exceeding Wall Street projections.
• RKLB’s upcoming Nasdaq-100 inclusion on June 22 may trigger increased demand from index-tracking funds.

Arjun Kampani, Senior Vice President and General Counsel at Rocket Lab (RKLB), executed a sale of 88,000 shares on June 18, with an average transaction price of $107.98. The sale generated proceeds of approximately $9.5 million.

Rocket Lab USA, Inc., RKLB

After completing this transaction, Kampani maintains direct ownership of 264,705 shares, currently worth about $28.6 million. The sale decreased his personal holdings by 24.95%.

This transaction is part of a broader selling pattern. Kampani previously disposed of 28,668 shares on May 26 at $142.57 each, followed by 70,000 shares on May 27 at $145.13, and an additional 23,804 shares on May 28 at $147.43.

Throughout the last twelve months, Kampani has divested 342,714 shares in total. The company has registered 43 insider sales during this timeframe, with no insider purchases reported whatsoever.

RKLB stock decreased by $0.74 during the session, settling at $107.24. Trading activity reached 70.2 million shares — roughly triple the standard daily volume of 24.8 million.

Share Price Maintains Elevation Above Key Averages

Notwithstanding recent weakness, RKLB continues trading substantially above its 200-day moving average of $82.68 and its 50-day moving average of $104.00. The stock has fluctuated between $27.84 and $151.00 over the past 52 weeks.

The company’s market capitalization currently stands at $62.07 billion. With a price-to-earnings ratio of -335.12, Rocket Lab remains unprofitable. The stock’s beta of 2.49 indicates significant volatility relative to broader market movements.

Wall Street analysts have established a consensus price target of $102.76 with a “Moderate Buy” recommendation. Target estimates span from $105 (KGI Securities, neutral stance) to $150 (New Street Research, buy rating). Stifel Nicolaus maintains a $132 target, while KeyCorp recently elevated its rating to overweight with a $135 price objective.

Robust Financial Performance Despite Valuation Concerns

Rocket Lab’s latest quarterly results, released May 7, showed revenue of $200.35 million, surpassing analyst projections of $189.65 million by approximately $10.7 million.

Year-over-year revenue climbed 63.4%. The company reported earnings per share of -$0.07, aligning with expectations. Rocket Lab maintains a substantial backlog valued at $2.2 billion.

The company recently successfully completed a critical Space Development Agency evaluation, bolstering its position in defense contracting.

Beginning June 22, RKLB will join the Nasdaq-100 index. This addition generally prompts passive investment from index funds and exchange-traded funds that replicate the index composition.

Institutional investors control 71.78% of outstanding shares. Major stakeholders include Vanguard with 47.4 million shares, Baillie Gifford holding 17.9 million, and Capital World Investors with 16.2 million shares.

According to GuruFocus analysis, the stock’s fundamental value sits at $26.42, resulting in a price-to-GF-Value multiple of 4.09 — a metric the platform characterizes as significantly overvalued.

Analyst consensus forecasts full-year earnings per share of -$0.29 for the current fiscal period.

The post Rocket Lab (RKLB) Stock Dips Following $9.5M Insider Share Sale by Senior Vice President appeared first on Blockonomi.